Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

BACKGROUND: The clinical significance of circulating tumour cells (CTCs) in limited-stage small-cell lung cancer (LS-SCLC) is not well defined. We report a planned exploratory analysis of the prevalence and prognostic value of CTCs in LS-SCLC patients enrolled within the phase III randomised CONVERT...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, R Y, Fernández-Gutiérrez, F, Foy, V, Burns, K, Pierce, J, Morris, K, Priest, L, Tugwood, J, Ashcroft, L, Lindsay, C R, Faivre-Finn, C, Dive, C, Blackhall, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637373/
https://www.ncbi.nlm.nih.gov/pubmed/31020334
http://dx.doi.org/10.1093/annonc/mdz122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637373/
https://www.ncbi.nlm.nih.gov/pubmed/31020334
http://dx.doi.org/10.1093/annonc/mdz122

Ejemplares similares